Quick View
| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥207.3B | ¥202.9B | +2.2% |
| Operating Income | −¥11.9B | ¥17.3B | +12.9% |
| Ordinary Income | −¥19.4B | ¥11.6B | +1.1% |
| Net Income | −¥20.6B | −¥1.2B | −1570.7% |
| ROE | −31.3% | −1.4% | - |
Executive Summary
Fiscal 2026 Q3 results show revenue of 207.3B yen (YoY +2.2%) with severe profitability deterioration, recording operating loss of -11.9B yen (prior year operating income of 17.3B yen), ordinary loss of -19.4B yen (prior year ordinary income of 11.6B yen), and net loss of -20.6B yen (prior year net loss of -1.2B yen, YoY -1570.7%). The company shifted from operating profitability to significant losses, with gross profit margin at 9.2% and operating margin at -5.7%. Interest expenses of 8.7B yen represent a substantial financial burden, compressing profitability beyond operating levels. Equity ratio declined to 14.4% with negative retained earnings of -21.3B yen, indicating deteriorating financial stability. The full-year forecast projects revenue of 288.4B yen (YoY +8.9%) but anticipates net loss of -22.8B yen with no dividend, maintaining conservative capital preservation policy.
Performance Drivers
Revenue increased 2.2% YoY to 207.3B yen, driven by modest top-line expansion. However, gross profit of 19.0B yen translates to a low gross margin of 9.2%, indicating limited pricing power or unfavorable product mix. The primary profitability deterioration occurred at the operating level, where selling, general and administrative expenses of 30.9B yen (14.9% of revenue) exceeded gross profit, resulting in operating loss of -11.9B yen versus prior year operating income of 17.3B yen, a reversal of 29.2B yen. This represents structural deterioration in core business economics. Non-operating expenses totaled 8.9B yen, predominantly interest expense of 8.7B yen, reflecting the burden of a highly leveraged capital structure. The gap between operating loss of -11.9B yen and ordinary loss of -19.4B yen (7.5B yen difference, 3.6% of revenue) is attributable to this financing cost burden. Non-operating income of 1.4B yen provided limited offset. Extraordinary losses of 0.1B yen from asset disposal were minimal. Income tax expense of 1.1B yen despite pre-tax loss of -19.5B yen results in an effective tax rate of -5.5%, likely due to non-deductible expenses or minimal tax benefit recognition. The performance pattern is revenue up/profit down, characterized by modest revenue growth failing to offset cost structure inefficiencies and high financing costs, resulting in comprehensive losses across all profit levels.
Key Metrics
[Profitability] ROE of -31.3% reflects severe capital efficiency deterioration, driven by net loss of -20.6B yen against average equity. Operating margin of -5.7% indicates core operations are loss-making before financial costs. Gross profit margin of 9.2% is structurally low, limiting operating leverage. Net profit margin of -9.9% demonstrates comprehensive unprofitability. DuPont decomposition shows ROE driven by net margin of -9.9%, asset turnover of 0.454, and financial leverage of 6.95x, with negative profitability amplified by high leverage. [Cash Quality] Cash and deposits of 34.2B yen declined 39.2% YoY from 56.4B yen, indicating significant cash consumption. Short-term debt coverage stands at 5.75x (cash/short-term borrowings of 6.0B yen), maintaining immediate liquidity but with eroding buffer. Interest coverage ratio of -1.37x (operating income/interest expense) signals debt service stress, as interest expense exceeds operating earnings. [Investment Efficiency] Asset turnover of 0.454 is below the industry IT/Telecom median of 0.67, reflecting capital-intensive operations with property, plant and equipment of 355.9B yen (77.9% of total assets) increasing 28.4% YoY. Receivables turnover of 86 days (DSO) exceeds industry median of 61 days, indicating collection delays. Working capital turnover of 14.6B yen with operating working capital days suggesting room for efficiency improvement. [Financial Health] Equity ratio of 14.4% is substantially below the industry median of 59.2%, indicating high financial risk. Current ratio of 120.3% and quick ratio of 120.0% provide baseline liquidity, though declining cash balances warrant monitoring. Debt-to-equity ratio of approximately 5.95x significantly exceeds industry norms, driven by long-term loans of 48.0B yen and lease obligations of 226.4B yen in non-current liabilities. Financial leverage of 6.95x amplifies both returns and losses. Retained earnings turned negative at -21.3B yen from -0.7B yen YoY, eroding equity cushion.
Cash Flow Analysis
Cash and deposits declined 22.1B yen to 34.2B yen, representing a 39.2% YoY decrease and signaling substantial cash consumption. This decline occurred despite modest revenue growth, suggesting operating cash generation was insufficient to cover investing and financing obligations. The 20.6B yen net loss directly pressures cash reserves, while interest expense of 8.7B yen represents a significant cash outflow. Property, plant and equipment increased 78.8B yen (28.4% YoY) to 355.9B yen, indicating major capital deployment that absorbed substantial cash resources, though exact capex figures are unreported. This investment intensity in fixed assets, combined with operating losses, likely produced negative free cash flow. Working capital management shows trade receivables of 48.6B yen with extended collection cycle of 86 days, tying up operating cash. Trade payables of 2.1B yen are minimal relative to receivables, providing limited supplier financing benefit. Lease obligations totaling 229.9B yen (current 3.5B yen, non-current 226.4B yen) impose ongoing payment commitments. The cash coverage ratio of 5.75x against short-term borrowings of 6.0B yen maintains near-term solvency, but the accelerating cash decline from 56.4B yen to 34.2B yen constrains financial flexibility and elevates refinancing risk given the high debt burden.
Earnings Quality
Ordinary loss of -19.4B yen versus operating loss of -11.9B yen reflects net non-operating expense of 7.5B yen, representing 3.6% of revenue. Non-operating expenses totaled 8.9B yen, predominantly interest expense of 8.7B yen, which constitutes the primary non-operating drag. Non-operating income of 1.4B yen provided modest offset, with other non-operating income of 0.4B yen as the main component. The heavy interest burden reflects the company's leveraged capital structure, with this financial cost being recurring in nature rather than transitory. Extraordinary items were minimal at 0.1B yen loss from asset disposal, indicating core results are not materially distorted by one-time events. The gap between operating and net income is structurally driven by debt service costs rather than non-recurring gains or losses. Operating cash flow data is unreported for this quarterly period, precluding direct assessment of cash conversion quality, though the sharp decline in cash balances despite positive revenue suggests operating cash generation is weak or negative. The combination of negative operating income and high recurring interest expense indicates low earnings quality with negative cash characteristics. Income tax expense of 1.1B yen despite pre-tax loss suggests limited ability to realize tax benefits, consistent with strained profitability. The effective tax rate of -5.5% signals tax structure complexities that do not materially improve cash earnings.
Guidance Update
Full-year forecast projects revenue of 288.4B yen (YoY +8.9%), operating loss of -10.4B yen, ordinary loss of -20.7B yen, and net loss of -22.8B yen. Q3 cumulative revenue of 207.3B yen represents 71.9% progress toward the full-year target, tracking above the standard 75% benchmark for Q3. Operating loss of -11.9B yen already exceeds the full-year forecast loss of -10.4B yen by 14.4%, indicating potential downside risk to guidance unless Q4 achieves material improvement. Ordinary loss of -19.4B yen represents 93.7% of the full-year forecast of -20.7B yen, suggesting limited additional deterioration is expected. Net loss of -20.6B yen represents 90.4% of the forecasted full-year loss of -22.8B yen, consistent with the trajectory. The revenue progress rate above standard while loss levels approach full-year estimates suggests the company anticipates Q4 sequential improvement or stabilization. However, given the structural challenges of low gross margins (9.2%), high SG&A burden (14.9% of revenue), and substantial interest expense (8.7B yen), achieving meaningful profitability turnaround in Q4 appears challenging without significant operational intervention. Earnings per share forecast of -70.35 yen aligns with projected net loss. The company maintains no dividend forecast, consistent with loss-making status and capital preservation priorities.
Risk Factors
High financial leverage with debt-to-equity ratio of approximately 5.95x and interest coverage ratio of -1.37x creates debt service stress, as interest expense of 8.7B yen exceeds operating earnings. This leverage amplifies downside risk and constrains financial flexibility, particularly given declining cash reserves of 34.2B yen (down 39.2% YoY). Refinancing risk is elevated given the heavy reliance on long-term debt and lease obligations totaling 274.4B yen. Low gross profit margin of 9.2% combined with high SG&A expense ratio of 14.9% results in structurally negative operating profitability, requiring either significant pricing improvement, product mix optimization, or cost reduction to restore viability. Without margin expansion, revenue growth alone cannot drive recovery. Capital intensity with property, plant and equipment of 355.9B yen (77.9% of assets) increasing 28.4% YoY creates elevated fixed cost burden and depreciation exposure. If asset utilization or investment returns fall short, impairment risk and further ROIC deterioration could materialize, compounding capital efficiency challenges.
Industry Benchmark (Reference - Proprietary Data)
[Industry Position] (Reference - Proprietary Analysis) Profitability: ROE -31.3% (Industry Median 8.3%), ROA -4.5% implied (Industry Median 3.9%), Operating Margin -5.7% (Industry Median 8.2%), Net Profit Margin -9.9% (Industry Median 6.0%). The company's profitability metrics fall significantly below industry standards across all dimensions, with negative returns versus positive median peer performance. Financial Health: Equity Ratio 14.4% (Industry Median 59.2%), Current Ratio 1.20x (Industry Median 2.15x), Financial Leverage 6.95x (Industry Median 1.66x). Capital structure is materially weaker than industry norms, with substantially higher leverage and lower equity cushion. Efficiency: Asset Turnover 0.454 (Industry Median 0.67), Receivables Days 86 (Industry Median 61 days). Operating efficiency lags peers, particularly in working capital management with extended collection cycles. Revenue Growth 2.2% (Industry Median 10.4%) trails sector momentum. The company's positioning reflects distressed operational and financial characteristics relative to the IT/Telecom sector, ranking in the bottom quartile across key financial health and profitability metrics. (Industry: IT/Telecom, Comparison: 2025-Q3 sector medians, n=94-104 companies, Source: Proprietary analysis)
Key Takeaways from Earnings
Structural profitability challenges with operating loss of -11.9B yen and gross margin of only 9.2% indicate core business economics require fundamental improvement through pricing power enhancement, cost structure reduction, or business model adjustment. The reversal from prior year operating income of 17.3B yen to current operating loss represents a 29.2B yen deterioration, signaling urgent need for operational turnaround initiatives. Elevated financial risk from debt-to-equity of approximately 5.95x and negative interest coverage of -1.37x creates refinancing vulnerability and limits strategic flexibility. The 39.2% decline in cash reserves to 34.2B yen while maintaining high debt service obligations of 8.7B yen annually suggests liquidity pressures may intensify absent operational cash flow improvement or capital restructuring. The 28.4% increase in property, plant and equipment to 355.9B yen reflects significant capital deployment that has not yet translated to profitability, indicating investment returns are below hurdle rates and asset utilization or project execution warrant close monitoring for potential impairment. Extended receivables collection of 86 days versus industry median of 61 days highlights working capital inefficiency that ties up scarce cash resources. Recovery pathway depends on simultaneous gross margin expansion, SG&A rationalization, and debt burden reduction, with absence of dividend reflecting appropriate capital preservation given negative earnings and stressed balance sheet. Full-year guidance suggesting Q4 stabilization requires validation through tangible operational improvements.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.
AI Financial Analysis
Executive Summary
FY2026 Q3 performance was materially weak, with a modest sales increase unable to offset a sharp deterioration in gross profitability, elevated fixed costs, and a rising financing burden. Nine-month revenue increased 2.2% year on year to ¥20.734bn. Gross profit fell 58.1% to ¥1.899bn despite the revenue increase. Gross margin contracted to 9.2% from 22.4% in the prior-year period, a severe 1,320bp decline. SG&A expense rose 10.2% to ¥3.092bn and represented 14.9% of sales, up 110bp year on year. Consequently, operating income moved from a ¥1.733bn profit to a ¥1.192bn loss. The operating margin deteriorated by 1,429bp, from 8.5% to negative 5.8%. Ordinary loss widened to ¥1.943bn as interest expense increased 45.9% to ¥870m. Net loss was ¥2.055bn, compared with a ¥123m loss in the prior-year period. The annualized DuPont ROE was negative 41.7%, reflecting the negative net margin rather than a lack of asset utilization or leverage. Financial leverage of 6.95x substantially magnifies the effect of operating losses on shareholder value. Cash and deposits declined 39.2% year on year to ¥3.425bn while property, plant and equipment increased 28.4% to ¥35.585bn. The balance sheet is therefore increasingly capital intensive, with PPE accounting for 77.9% of total assets. The full-year revenue forecast of ¥28.844bn implies a significant fourth-quarter sales contribution, while management expects the operating loss to narrow from ¥1.192bn after Q3 to ¥1.039bn for the full year. The implied Q4 operating profit of approximately ¥153m requires a return to positive operating profitability and is dependent on meaningful gross-margin recovery and cost control. The no-dividend policy is appropriate given the loss position, negative retained earnings, and high leverage. The central issues for the outlook are whether newly deployed facilities can improve utilization and unit economics quickly enough to restore gross margin, and whether financing costs remain manageable during that ramp-up.
Profitability Analysis
The reported annualized DuPont ROE of negative 41.7% is decomposed into a negative 9.9% net profit margin, 0.605x asset turnover, and 6.95x financial leverage. The net margin is the principal driver of the negative ROE, while high leverage amplifies the loss attributable to equity holders. Gross margin fell to 9.2% from 22.4% in the prior-year period, a 1,320bp deterioration, and was the largest adverse change in the earnings structure. SG&A increased to ¥3.092bn from ¥2.805bn, or 10.2% year on year, materially above 2.2% sales growth. This created negative operating leverage: SG&A rose while gross profit declined by ¥2.639bn. Operating margin consequently fell from 8.5% to negative 5.8%. The negative 1.37x interest coverage ratio indicates that EBIT was insufficient to cover the ¥870m interest expense. Interest expense equaled 4.2% of revenue, versus 2.9% in the comparable period, and widened the gap between operating loss and ordinary loss. The five-factor interest-burden ratio is not economically meaningful with negative EBIT and pre-tax income, but its reported 1.634 value reflects losses at both levels rather than debt-servicing capacity. Annualized ROIC of negative 18.6% indicates that the expanded asset base is currently generating returns well below the cost of financing. Sustained recovery requires gross-margin normalization, improved facility utilization, and SG&A discipline; without these, scale alone is unlikely to repair returns.
Growth Assessment
Revenue growth of 2.2% to ¥20.734bn was modest relative to the 28.4% increase in PPE, indicating that the enlarged operating asset base has not yet translated into commensurate sales growth. Accounts receivable increased 19.5% to ¥4.862bn, faster than sales, and reported DSO reached 64 days. The growth profile is therefore currently capital intensive and accompanied by a weaker cash conversion cycle indicator. The full-year revenue forecast is ¥28.844bn, implying a 71.9% progress rate after Q3, 3.1 percentage points below the standard 75% nine-month progress benchmark. Achieving the forecast requires approximately ¥8.110bn of Q4 revenue. The full-year operating-loss forecast is ¥1.039bn, versus a ¥1.192bn loss reported through Q3, implying approximately ¥153m of Q4 operating profit. The full-year net-loss forecast of ¥2.281bn implies a further Q4 net loss of about ¥226m, primarily reflecting financing and other non-operating costs despite the implied operating recovery. For a care-facility operator, the key operating variables are facility opening ramp-up, occupancy, staffing availability, wage inflation, and reimbursement conditions. The sharp gross-margin decline suggests that cost absorption and/or utilization has weakened materially during expansion. The fourth-quarter recovery embedded in guidance is achievable only if incremental revenue carries substantially better contribution margins than the nine-month average.
Financial Health
Liquidity is adequate on a narrow current-account basis, with a current ratio of 120.3%, quick ratio of 120.0%, and working capital of ¥1.463bn. Cash and deposits of ¥3.425bn exceed short-term loans of ¥596m by 5.75x. Cash also exceeds the ¥1.039bn current portion of long-term loans and ¥15m current portion of bonds, providing near-term debt-servicing flexibility. However, the current ratio is below the 1.5x level generally associated with a stronger liquidity cushion, and cash declined by ¥2.212bn year on year. Solvency is the principal balance-sheet concern. The debt-to-equity ratio is 5.95x, well above the 2.0x warning threshold, indicating aggressive debt financing relative to the ¥6.570bn equity base. Total liabilities represent 85.6% of total assets, while the equity ratio declined to 14.3% from 22.0% a year earlier. Lease obligations total ¥22.993bn, comprising ¥354m current and ¥22.639bn non-current, and are a major fixed contractual obligation alongside ¥5.396bn of reported interest-bearing debt. Long-term loans decreased to ¥4.800bn from ¥5.580bn, but this reduction was more than offset by the expansion in lease obligations and broader non-current liabilities. PPE increased ¥7.879bn to ¥35.585bn, including lease assets of ¥21.869bn, reinforcing reliance on long-lived facility assets to support the business model. Retained earnings deteriorated from negative ¥74m to negative ¥2.129bn, reducing loss-absorption capacity. Asset retirement obligations of ¥607m also represent a relevant long-term obligation associated with the facility footprint.
Notable B/S Changes
Retained earnings: -¥2.055bn year on year, from -¥74m to -¥2.129bn (-2,777.0%) - nine-month net loss materially weakened accumulated loss-absorption capacity. Cash and deposits: -¥2.212bn (-39.2%) to ¥3.425bn - liquidity declined while the company continued to expand its fixed-asset base. PPE: +¥7.879bn (+28.4%) to ¥35.585bn - significant facility and lease-asset expansion increases the requirement for improved utilization and operating returns. Lease obligations: +¥7.843bn (+51.8%) to ¥22.993bn - fixed contractual commitments increased substantially and heighten operating leverage. Accounts receivable: +¥794m (+19.5%) to ¥4.862bn - growth exceeded revenue growth and is consistent with the elevated 64-day DSO. Total equity: -¥2.046bn (-23.7%) to ¥6.570bn - the equity ratio declined to 14.3%, increasing sensitivity to further losses.
Cash Flow Quality
Cash and deposits declined by ¥2.212bn year on year to ¥3.425bn, coinciding with an ¥7.879bn increase in PPE. This combination indicates substantial capital deployment into the operating footprint while reported earnings turned deeply negative. The balance sheet is heavily weighted toward long-lived assets, with PPE representing 77.9% of total assets, making future cash generation sensitive to utilization and operating margins at those facilities. Receivables increased by ¥794m, or 19.5%, versus only 2.2% revenue growth. The resulting 64-day DSO exceeds the 60-day quality-alert threshold and should be monitored for collection discipline and payer-mix effects. Inventories remain immaterial at ¥19m, so working-capital risk is concentrated in receivables rather than stock. The decline in cash, combined with negative EBIT and substantial lease obligations, raises the importance of restoring operating profitability before further large-scale expansion. Cash flow quality should be assessed primarily through the pace of receivable collections, facility-level cash contribution, and the relationship between future operating profit recovery and cash balance preservation.
Dividend Sustainability
The company reported a ¥0 Q2 dividend per share and forecasts a ¥0 full-year dividend per share. With EPS of negative ¥63.37 through Q3 and forecast full-year EPS of negative ¥70.35, a dividend payout ratio is not meaningful. The zero-dividend policy preserves liquidity during a period of operating losses, negative retained earnings of ¥2.129bn, and high debt relative to equity. It is also consistent with the need to absorb interest expense of ¥870m and support an asset-intensive operating model. Dividend resumption would require a sustained return to profitability, stabilization of the equity base, and improved coverage of financing obligations.
Risk Assessment
Business risks include Margin and utilization risk: gross margin fell 1,320bp to 9.2%, indicating that revenue expansion is not currently covering direct operating costs effectively., Care-facility ramp-up risk: the 28.4% increase in PPE requires occupancy and staffing productivity to improve sufficiently to absorb fixed facility costs., Labor-cost and staffing risk: care-service operations are exposed to wage inflation, hiring constraints, and employee retention pressures, which can further compress already-low gross margins., Receivable-collection risk: DSO of 64 days exceeds the 60-day alert threshold, while receivables rose 19.5%, faster than revenue growth..
Financial risks include High leverage risk: D/E of 5.95x exceeds the 2.0x warning threshold and leaves equity highly exposed to further operating losses., Debt-service risk: EBIT was negative and interest coverage was negative 1.37x, while interest expense rose to ¥870m from ¥596m., Lease-obligation risk: total lease obligations of ¥22.993bn create substantial fixed commitments relative to ¥6.570bn of equity and ¥3.425bn of cash., Liquidity erosion risk: cash declined 39.2% year on year, reducing flexibility if operating recovery or receivable collection is delayed..
Key concerns include The most significant risk is the combination of negative 5.8% EBIT margin, negative 18.6% annualized ROIC, and high financial leverage., The full-year outlook assumes a swing to approximately ¥153m of Q4 operating profit after a ¥1.192bn nine-month operating loss; execution against that recovery is critical., The asset base expanded faster than sales, raising the risk that returns remain depressed if facility utilization does not accelerate., Further losses would reduce the 14.3% equity ratio and could make refinancing, lease funding, and future expansion more restrictive..
Investment Implications
Key takeaways include Nine-month revenue growth of 2.2% was insufficient to offset a ¥2.639bn decline in gross profit and a 10.2% increase in SG&A., Operating performance shifted from an ¥1.733bn profit to a ¥1.192bn loss, with gross margin falling to 9.2%., High D/E of 5.95x and negative interest coverage make operating recovery and financing-cost containment central to the financial profile., PPE growth of ¥7.879bn and lease obligations of ¥22.993bn increase the sensitivity of equity value to facility utilization and margin recovery., No dividend is expected for the year, consistent with capital preservation needs..
Metrics to watch include Gross margin and operating margin recovery versus the Q3 levels of 9.2% and negative 5.8%, Q4 revenue delivery relative to the implied ¥8.110bn needed to meet full-year guidance, Q4 operating result relative to the implied approximately ¥153m operating profit, Interest expense and interest coverage, Cash and deposits, lease obligations, and the equity ratio, Accounts receivable growth and DSO relative to the current 64 days, PPE growth relative to revenue growth and facility-level utilization.
Regarding relative positioning, The company currently exhibits a high-risk operating and financial profile relative to conventional profitability and solvency benchmarks: gross margin is below the 20% alert threshold, EBIT margin is negative, annualized ROIC is negative, D/E materially exceeds 2.0x, and interest coverage is negative. Its current and quick ratios remain above 1.0x, but the balance-sheet cushion is limited by declining cash, a 14.3% equity ratio, and large lease commitments.